Covered recipient · General Payments record
HA T PHAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$1,343.74
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $784.97 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $400.25 | 17 |
| Gilead Sciences, Inc. | $88.18 | 1 |
| Alexion Pharmaceuticals, Inc. | $38.73 | 2 |
| BTG INTERNATIONAL, INC. | $37.89 | 2 |
| PFIZER INC. | $36.98 | 2 |
| PharmaEssentia USA Corporation | $33.86 | 1 |
| Karyopharm Therapeutics Inc. | $22.97 | 1 |
| Incyte Corporation | $21.35 | 1 |
| SpringWorks Therapeutics, Inc. | $20.25 | 1 |
| Genmab U.S., Inc. | $20.24 | 1 |
| Celgene Corporation | $16.85 | 1 |
| JAZZ PHARMACEUTICALS INC. | $16.53 | 1 |
| Daiichi Sankyo Inc. | $16.00 | 1 |
| Janssen Biotech, Inc. | $14.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.33 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843945 | CMS |
| ABBVIE INC. | $17.01 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843947 | CMS |
| ABBVIE INC. | $28.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843949 | CMS |
| ABBVIE INC. | $14.12 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843951 | CMS |
| ABBVIE INC. | $26.56 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843953 | CMS |
| ABBVIE INC. | $12.00 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843955 | CMS |
| ABBVIE INC. | $27.50 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843957 | CMS |
| ABBVIE INC. | $12.71 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843959 | CMS |
| ABBVIE INC. | $27.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843961 | CMS |
| ABBVIE INC. | $25.60 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843963 | CMS |
| ABBVIE INC. | $28.33 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843965 | CMS |
| ABBVIE INC. | $21.89 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843967 | CMS |
| ABBVIE INC. | $33.75 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843969 | CMS |
| ABBVIE INC. | $33.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843971 | CMS |
| ABBVIE INC. | $26.45 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843973 | CMS |
| ABBVIE INC. | $8.85 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843975 | CMS |
| ABBVIE INC. | $28.34 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107843977 | CMS |
| Alexion Pharmaceuticals, Inc. | $14.20 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093996449 | CMS |
| Alexion Pharmaceuticals, Inc. | $24.53 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094010326 | CMS |
| BTG International, Inc. | $19.10 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134497758 | CMS |
| BTG International, Inc. | $18.79 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138634951 | CMS |
| Celgene Corporation | $16.85 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101180662 | CMS |
| Daiichi Sankyo Inc. | $16.00 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089469195 | CMS |
| Genmab U.S., Inc. | $20.24 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126835814 | CMS |
| Gilead Sciences, Inc. | $88.18 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133657838 | CMS |
| Incyte Corporation | $21.35 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141221502 | CMS |
| Janssen Biotech, Inc. | $14.89 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078496961 | CMS |
| JAZZ PHARMACEUTICALS INC. | $16.53 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151308886 | CMS |
| Karyopharm Therapeutics Inc. | $22.97 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145539474 | CMS |
| PFIZER INC. | $18.82 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131590119 | CMS |
| PFIZER INC. | $18.16 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131360909 | CMS |
| PharmaEssentia USA Corporation | $33.86 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137308180 | CMS |
| SpringWorks Therapeutics, Inc. | $20.25 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085810584 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.